Efficacy of adjuvant colistimethate sodium nebulization in ventilator associated pneumonia in pediatric intensive care unit - A randomized controlled study
Background and Objective: The treatment of ventilator-associated pneumonia (VAP) caused by multidrug resistant organisms is challenging even with appropriate intravenous antibiotics. The study was conducted to evaluate the efficacy and safety of nebulised Colistimethate sodium (CS) in the treatment...
Main Authors: | Anil Sachdev, Neeraj Kumar Sagar, Dhiren Gupta, Neeraj Gupta, Suresh Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Pediatric Critical Care |
Subjects: | |
Online Access: | http://www.jpcc.org.in/article.asp?issn=2349-6592;year=2019;volume=6;issue=3;spage=15;epage=20;aulast=Sachdev |
Similar Items
-
Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
by: Yinggang Zhu, et al.
Published: (2021-05-01) -
Intrapulmonary and Systemic Pharmacokinetics of Colistin Following Nebulization of Low-Dose Colistimethate Sodium in Patients with Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Dong-Hwan Lee, et al.
Published: (2024-03-01) -
Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population
by: K S Bharathi, et al.
Published: (2022-01-01) -
Effect of Nebulized Eucalyptus on Ventilator Associated Pneumonia in Ventilated Patients
by: Nazanin Amini, et al.
Published: (2019-12-01) -
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features
by: Gennaro De Pascale, et al.
Published: (2023-01-01)